Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-05 · accession 0001649094-24-000118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-09 | 2024-12-09 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $92.06 | -475 | 28.2K | -2% | -$43.7K |
| DM | 2024-12-09 | 2024-12-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $91.48 | -5,000 | 32.3K | -13% | -$457.4K |
| D | 2024-12-09 | 2024-12-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | G - Gift | $0.00 | -110 | 28.7K | -0.4% | $0 |
| D | 2024-12-09 | 2024-12-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.7K | +17% | +$107.0K |
| D | 2024-12-09 | 2024-12-05 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -5,000 | 159.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | F | D | 475 | $92.06 | 28,222 | D | — | — | (F7) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2024-12-05 | S | D | 3,177 | $91.91 | 29,085 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $91.265 to $92.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-12-05 | S | D | 388 | $92.90 | 28,697 | D | — | — | (F6) The price reported is a weighted-average price. The shares were sold at prices ranging from $92.29 to $93.11. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-12-05 | G | D | 110 | $0.00 | 28,697 | D | — | — | (F1) Represents a bona fide gift of the Issuer's Common Stock to a non-profit educational institution. (F2) Includes 184 shares acquired on November 15, 2024 under the Issuer's Employee Stock Purchase Plan. |
| 5 | Common | Common Stock | 2024-12-05 | M | A | 5,000 | $21.41 | 33,697 | D | — | — | |
| 6 | Common | Common Stock | 2024-12-05 | S | D | 1,435 | $90.16 | 32,262 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $89.655 to $90.645. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Derivative | Stock Option (right to buy) | 2024-12-05 | M | D | 5,000 | $0.00 | 159,497 | D | $21.41 · — to 2032-05-08 | 5,000 Common Stock | (F8) 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |